T. Rowe Price Associates
CVS icon

T. Rowe Price Associates’s CVS Health CVS Stock Holding History

T. Rowe Price Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-200,000
Closed -$12.4M – 2586
2018
Q1 		$12.4M Hold
200,000
– – ﹤0.01% 1296
2017
Q4 		$14.5M Hold
200,000
– – ﹤0.01% 1276
2017
Q3 		$16.3M Buy
+200,000
New +$15.8M ﹤0.01% 1244

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates's CVS Position: Q2 2026 in Review

T. Rowe Price Associates increased its CVS Health (CVS) stake by 1.8% in Q2 2026, buying an estimated $37.6M and bringing the position to 24,203,884 shares worth $2.5B. The position accounts for 0.25% of the portfolio, ranked #74.

T. Rowe Price Associates first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • T. Rowe Price Associates held 24,203,884 shares of CVS Health worth $2.5B as of Q2 2026.
  • T. Rowe Price Associates bought 420,739 CVS Health shares in Q2 2026, an estimated $37.6M.
  • CVS Health made up 0.25% of T. Rowe Price Associates's portfolio in Q2 2026, its #74 holding.
  • T. Rowe Price Associates first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.